Selepressin

Star0

DB12495InvestigationalSmall molecule

Selepressin has been used in trials studying the treatment of Septic Shock.

Mechanism: Pharmacologically active on Vasopressin V1a receptor
Curator reviewed
Formula / weight: C₄₆H₇₃N₁₃O₁₁S₂ · 1048.29 g/mol (avg)
Code names: FE-202158

Resolves to

Compound

UNII8P2T76M0SJCAS876296-47-8ChEMBLCHEMBL1817709PubChem53330936

Structure

InChIKeyJCVQBJTWWDYUFQ-MRUTUVJXSA-NSMILES

CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O

Targets

P37288AVPR1A

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Selepressin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account